Ryan Wingo
Story Poster
62:55
Ask Liucci: Going bowling in Las Vegas, all eyes on the portal & more
2 days ago by Billy Liucci
It's a busy part of the college football season as Texas A&M is preparing for the 2024 SRS Las Vegas Bowl AND scouring the transfer portal for important additions. With so much going on, Billy Liucci tackled another round of subscriber questions on those topics and more.
Story Poster
Learned, Loved, Loathed: Texas 17, Texas A&M 7
20 days ago by Olin Buchanan
Between a lack of creativity on offense and the defense's inability to stop the run, Texas A&M suffered a back-breaking 17-7 loss to arch-rival Texas on Saturday night at Kyle Field. Olin Buchanan shares what he learned, loved and loathed about the Aggies' performance.
Story Poster
Post Game Review: No. 3 Texas 17, No. 20 Texas A&M 7
20 days ago by Kay Naegeli
In the resumption of the Lone Star Showdown, Texas A&M's offense remained bottled up all night as the Aggies fell to their arch-rivals, 17-7, with Texas punching its ticket to Atlanta. A&M finishes the regular season 8-4 and 5-3 in SEC play.
Get access to all Premium content today
Start your subscription for just $1
Try Premium Now
Story Poster
28:37
Ask Liucci: Prepping for Pittman's Pigs in Arlington once again & more
2 mo ago by Billy Liucci
A pair of 3-1 teams meet in Arlington on Saturday afternoon as No. 24 Texas A&M and Arkansas will battle in the Southwest Classic at AT&T Stadium. Before heading to the DFW Metroplex, Billy Liucci answers another round of subscriber questions surrounding the Ags.
Story Poster
Longhorns join Southeastern Conference with grandiose expectations
5 mo ago by Olin Buchanan
Even with questions at receiver and on defense, Texas might have the talent and advantages to successfully navigate its maiden voyage through the SEC. But make no mistake, the transition from the Big 12 to the nation's premier conference may prove more perilous than it appears.
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.